Patient Guide: A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 42 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04041050
Status: ACTIVE_NOT_RECRUITING
Condition: Myeloproliferative Neoplasm
Phase: PHASE1

Where You Can Participate

This study is available at 42 locations across the country.

Top locations include:
  • • Duarte, California
  • • Fullerton, California
  • • La Jolla, California
  • • And 39 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm - Join Clinical Trial NCTNCT04041050

How to Join This Clinical Trial - NCTNCT04041050

Learn how to participate in this PHASE1 trial studying an investigational therapy for Myeloproliferative Neoplasm. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Myeloproliferative Neoplasm. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Myeloproliferative Neoplasm
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04041050 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 42 locations. Find a study site near you:

Clinical Research Site

Duarte, California 91010 - United States

Status: Contact for availability

Clinical Research Site

Fullerton, California 92835 - United States

Status: Contact for availability

Clinical Research Site

La Jolla, California 92093 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90095-1678 - United States

Status: Contact for availability

Clinical Research Site

Chicago, Illinois 60611-2927 - United States

Status: Contact for availability

Clinical Research Site

Louisville, Kentucky 40207 - United States

Status: Contact for availability

Clinical Research Site

Detroit, Michigan 48202-2610 - United States

Status: Contact for availability

Clinical Research Site

Omaha, Nebraska 68130 - United States

Status: Contact for availability

Clinical Research Site

Greenville, North Carolina 27834 - United States

Status: Contact for availability

Clinical Research Site

Canton, Ohio 44718 - United States

Status: Contact for availability

And 32 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Myeloproliferative Neoplasm:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships